Linli Li

3.0k citations

111 papers · 2.0k · h-index 26

Impact in

Computational Theory and Mathematics top 1%
- Computational Drug Discovery Methods
Molecular Biology top 10%
- Protein Structure and Dynamics
- Cancer-related gene regulation
- RNA modifications and cancer
- Epigenetics and DNA Methylation

Papers in

Molecular Biology 59
- Cancer therapeutics and mechanisms 7
- Receptor Mechanisms and Signaling 6
- Chemical Synthesis and Analysis 5
- Epigenetics and DNA Methylation 5
- Protein Kinase Regulation and GTPase Signaling 5
Computational Theory and Mathematics 26
- Computational Drug Discovery Methods 26

Co-authors: Shengyong Yang (64 shared papers)Yuquan Wei (16 shared papers)Guo‐Bo Li (7 shared papers)Huanzhang Xie (9 shared papers)Qi Huang (7 shared papers)Lingling Yang (7 shared papers)Wenjing Wang (8 shared papers)Ji-Xia Ren (4 shared papers)
Journals: Bioorganic & Medicinal Chemistry Letters (19 papers)Journal of Medicinal Chemistry (13 papers)European Journal of Medicinal Chemistry (9 papers)Journal of Chemical Information and Modeling (5 papers)Journal of Molecular Graphics and Modelling (4 papers)
Partner nations: China United States United Kingdom

In The Last Decade

Linli Li

108 papers receiving 2.0k citations

Peers

Countries citing papers authored by Linli Li

Since Specialization

Citations

This map shows the geographic impact of Linli Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linli Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linli Li more than expected).

Fields of papers citing papers by Linli Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linli Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linli Li. The network helps show where Linli Li may publish in the future.

Co-authors

The 25 scholars most cited alongside Linli Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Linli Li Line = papers co-authored together Linli Li links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 111 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	ID-Score: A New Empirical Scoring Function Based on a Comprehensive Set of Descriptors Related to Protein–Ligand Interactions Journal of Chemical Information and Modeling ·Guo‐Bo Li, Lingling Yang, Wenjing Wang, Linli Li, Sheng‐Yong Yang	2013	141
2	Pharmacophore modeling studies of type I and type II kinase inhibitors of Tie2 Journal of Molecular Graphics and Modelling ·Qingqing Xie, Huanzhang Xie, Ji-Xia Ren, Linli Li, Shengyong Yang	2008	99
3	Structure–Activity Relationship Studies of Pyrazolo[3,4-d]pyrimidine Derivatives Leading to the Discovery of a Novel Multikinase Inhibitor That Potently Inhibits FLT3 and VEGFR2 and Evaluation of Its Activity against Acute Myeloid Leukemia in Vitro and in Vivo Journal of Medicinal Chemistry ·Lingling Yang, Guo‐Bo Li, Shuang Ma, Chan Zou, Shu Zhou, Qizheng Sun, Chuan Cheng, Xin Chen, Lijiao Wang, Shan Feng, Linli Li, Shengyong Yang	2013	64
4	Discovery of Novel Pim-1 Kinase Inhibitors by a Hierarchical Multistage Virtual Screening Approach Based on SVM Model, Pharmacophore, and Molecular Docking Journal of Chemical Information and Modeling ·Ji-Xia Ren, Linli Li, Renlin Zheng, Huanzhang Xie, Zhixing Cao, Shan Feng, Youli Pan, Xin Chen, Yuquan Wei, Shengyong Yang	2011	59
5	Structure-activity relationship studies of phenothiazine derivatives as a new class of ferroptosis inhibitors together with the therapeutic effect in an ischemic stroke model European Journal of Medicinal Chemistry ·Wei Yang, Xiaolong Liu, Chunli Song, Sen Ji, Jianhong Yang, Yang Liu, Jing You, Jie Zhang, Shenzhen Huang, Wei Cheng, Zhenhua Shao, Linli Li, Shengyong Yang	2020	58
6	Generative deep learning enables the discovery of a potent and selective RIPK1 inhibitor Nature Communications ·Yueshan Li, Liting Zhang, Yifei Wang, Jun Zou, Ruicheng Yang, Xinling Luo, Chengyong Wu, Wei Yang, Chenyu Tian, Haixing Xu, Falu Wang, Xin Yang, Linli Li, Shengyong Yang	2022	55
7	Structural Optimization and Structure–Activity Relationships of N²-(4-(4-Methylpiperazin-1-yl)phenyl)-N⁸-phenyl-9H-purine-2,8-diamine Derivatives, a New Class of Reversible Kinase Inhibitors Targeting both EGFR-Activating and Resistance Mutations Journal of Medicinal Chemistry ·Jiao Yang, Lijiao Wang, Jingjing Liu, Lei Zhong, Renlin Zheng, Yong Xu, Pan Ji, Chunhui Zhang, Wenjing Wang, Xingdong Lin, Linli Li, Yuquan Wei, Shengyong Yang	2012	53
8	RASA: A Rapid Retrosynthesis-Based Scoring Method for the Assessment of Synthetic Accessibility of Drug-like Molecules Journal of Chemical Information and Modeling ·Qi Huang, Linli Li, Shengyong Yang	2011	51
9	Discovery of a potent, selective and cell active inhibitor of m6A demethylase ALKBH5 European Journal of Medicinal Chemistry ·Zhen Fang, Bo Mu, Yang Liu, Nihong Guo, Xiong Liang, Yinping Guo, Anjie Xia, Rong Zhang, Hailin Zhang, Rui Yao, Yan Fan, Linli Li, Shengyong Yang, Rong Xiang	2022	50
10	PhDD: A new pharmacophore-based de novo design method of drug-like molecules combined with assessment of synthetic accessibility Journal of Molecular Graphics and Modelling ·Qi Huang, Linli Li, Shengyong Yang	2010	48
11	An integrated scheme for feature selection and parameter setting in the support vector machine modeling and its application to the prediction of pharmacokinetic properties of drugs Artificial Intelligence in Medicine ·Shengyong Yang, Qi Huang, Linli Li, Chang-Ying Ma, Hui Zhang, Ru Bai, Qizhi Teng, Mingli Xiang, Yuquan Wei	2008	47
12	Discovery of a novel and potent inhibitor with differential species-specific effects against NLRP3 and AIM2 inflammasome-dependent pyroptosis European Journal of Medicinal Chemistry ·Jiao Yan, Jinshan Nan, Bo Mu, Yun Zhang, Nenghua Zhou, Shunhua Yang, (unknown), Shanshan Zhang, Wan-Ting Lin, Falu Wang, Anjie Xia, Zhixing Cao, Pei Chen, Zhiling Pan, Guifeng Lin, Shulei Pan, Huachao Bin, Linli Li, Shengyong Yang	2022	43
13	Non-classical ferroptosis inhibition by a small molecule targeting PHB2 Nature Communications ·Wei Yang, Bo Mu, Jing You, Chenyu Tian, Huachao Bin, Zhiqiang Xu, Liting Zhang, Ronggang Ma, Ming Wu, Guo Zhang, Chong Huang, Linli Li, Zhenhua Shao, Lunzhi Dai, Laurent Désaubry, Shengyong Yang	2022	41
14	α-MMC and MAP30, two ribosome-inactivating proteins extracted from Momordica charantia, induce cell cycle arrest and apoptosis in A549 human lung carcinoma cells Molecular Medicine Reports ·Fan Xiang, Lingli He, Yao Meng, Gangrui Li, Linli Li, Yanfa Meng	2015	40
15	PocketFlow is a data-and-knowledge-driven structure-based molecular generative model Nature Machine Intelligence ·Yuanyuan Jiang, Guo Zhang, Jing You, Hailin Zhang, Rui Yao, Huanzhang Xie, Liyun Zhang, Ziyi Xia, Mengzhe Dai, Yunjie Wu, Linli Li, Shengyong Yang	2024	37
16	Steered Molecular Dynamics Simulations Reveal the Likelier Dissociation Pathway of Imatinib from Its Targeting Kinases c-Kit and Abl PLoS ONE ·Lijun Yang, Jun Zou, Huanzhang Xie, Linli Li, Yuquan Wei, Shengyong Yang	2009	36
17	Discovery of Potent and Selective Inhibitors of Cdc2-Like Kinase 1 (CLK1) as a New Class of Autophagy Inducers Journal of Medicinal Chemistry ·Qizheng Sun, Guifeng Lin, Linli Li, Xi-Ting Jin, Luyi Huang, Guo Zhang, Wei Yang, Kai Chen, Rong Xiang, Chong Chen, Yuquan Wei, Guangwen Lu, Shengyong Yang	2017	36
18	Identification of 5-(2,3-Dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine Derivatives as a New Class of Receptor-Interacting Protein Kinase 1 (RIPK1) Inhibitors, Which Showed Potent Activity in a Tumor Metastasis Model Journal of Medicinal Chemistry ·Yueshan Li, Yu Xiong, Guo Zhang, Liting Zhang, Wei Yang, Jiao Yang, Luyi Huang, Zeen Qiao, Zhuang Miao, Guifeng Lin, Qiu Sun, Ting Niu, Lijuan Chen, Dawen Niu, Linli Li, Shengyong Yang	2018	36
19	Discovery of New SIRT2 Inhibitors by Utilizing a Consensus Docking/Scoring Strategy and Structure–Activity Relationship Analysis Journal of Chemical Information and Modeling ·Shenzhen Huang, Chunli Song, Xiang Wang, Guo Zhang, Yanlin Wang, Xiaojuan Jiang, Qizheng Sun, Luyi Huang, Rong Xiang, Yiguo Hu, Linli Li, Shengyong Yang	2017	36
20	Pharmacophore modeling study based on known Spleen tyrosine kinase inhibitors together with virtual screening for identifying novel inhibitors Bioorganic & Medicinal Chemistry Letters ·Huanzhang Xie, Linli Li, Ji-Xia Ren, Jun Zou, Yang Li, Yuquan Wei, Shengyong Yang	2009	34

About Linli Li

Linli Li is a scholar working on Molecular Biology, Computational Theory and Mathematics, Organic Chemistry, Oncology and Spectroscopy, having authored 111 papers that have together received 2.0k indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (26 papers), Analytical Chemistry and Chromatography (9 papers), Synthesis and biological activity (9 papers), Cancer therapeutics and mechanisms (7 papers), Receptor Mechanisms and Signaling (6 papers), Chemical Synthesis and Analysis (5 papers), Epigenetics and DNA Methylation (5 papers) and Protein Kinase Regulation and GTPase Signaling (5 papers). The work is most often cited by research in Computational Theory and Mathematics (550 citations), Molecular Biology (1.2k citations), Geriatrics and Gerontology (69 citations), Toxicology (57 citations) and Organic Chemistry (444 citations). Linli Li has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Shengyong Yang, Yuquan Wei, Guo‐Bo Li, Huanzhang Xie, Qi Huang, Lingling Yang, Wenjing Wang, Ji-Xia Ren, Jun Zou and Qingqing Xie. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry, Journal of Chemical Information and Modeling and Journal of Molecular Graphics and Modelling.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Linli Li

Impact in

Papers in i

In The Last Decade

Linli Li

Peers

Countries citing papers authored by Linli Li

Fields of papers citing papers by Linli Li

All Works

About Linli Li

Explore authors with similar magnitude of impact

Papers in